Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Dura to launch second Allergan product

June 20, 2000

Alcon discovers utility of glutamate antagonists for retinal disorders

June 9, 2000

Allergan and Xoma expand rBPI ophthalmic program

June 6, 2000

Visudyne therapy receives Canadian approval for treatment of wet AMD

June 2, 2000

Angiotech signs license agreement with Alcon for delivery of paclitaxel

May 30, 2000

Early use of PDT with verteporfin in age-related macular degeneration

May 24, 2000

New agents for cataracts designed by Sankyo

May 22, 2000

Squalamine demonstrates preclinical activity in retinopathy

May 19, 2000

Ciba Vision and QLT expand strategic alliance for developing new treatments for eye diseases

May 16, 2000

Special access program approved for Visudyne in Canada

May 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...